An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients: A Real-Life, Long-Term, Follow-Up, Clinical Practice in Italy.

MLA

Tocci, Giuliano, et al. “An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients: A Real-Life, Long-Term, Follow-Up, Clinical Practice in Italy.” High Blood Pressure & Cardiovascular Prevention, vol. 19, no. 2, May 2012, pp. 73–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104421440&authtype=sso&custid=ns315887.

APA

Tocci, G., Aimo, G., Caputo, D., De Matteis, C., Di Napoli, T., Granatelli, A., Lentini, P., Magagna, A., Matarrese, A. A., Perona, D., Villa, G., & Volpe, M. (2012). An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients: A Real-Life, Long-Term, Follow-Up, Clinical Practice in Italy. High Blood Pressure & Cardiovascular Prevention, 19(2), 73–83.

Chicago

Tocci, Giuliano, Gianpiero Aimo, Dario Caputo, Carmine De Matteis, Tommaso Di Napoli, Antonino Granatelli, Pietro Lentini, et al. 2012. “An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients: A Real-Life, Long-Term, Follow-Up, Clinical Practice in Italy.” High Blood Pressure & Cardiovascular Prevention 19 (2): 73–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104421440&authtype=sso&custid=ns315887.